ATHE
Alterity Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · AU
$4.54
+0.44%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+14.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 23, 2026 | Babarczy Julian Michael · director | A-Award | 2,000,000 | $1.00 |
| Jun 23, 2026 | Gozlan Lawrence Bernard · director | A-Award | 1,000,000 | $1.00 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 9Reduced 5Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Twin Lakes Capital Management, LLC | Unchanged | 139,258 | Aug 18, 2026 |
| TWIN LAKES CAPITAL MANAGEMENT, LLC | Unchanged | 139,258 | May 18, 2026 |
| MORGAN STANLEY | Increased | 63,065 | Aug 13, 2026 |
| GREENLEAF TRUST | Increased | 62,000 | Jul 21, 2026 |
| HB WEALTH MANAGEMENT, LLC | Unchanged | 58,460 | Apr 27, 2026 |
| HB Wealth Management, LLC | Unchanged | 58,460 | Jul 29, 2026 |
| MORGAN STANLEY | Reduced | 58,382 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 37,597 | Sep 2, 2026 |
| GREENLEAF TRUST | Unchanged | 32,000 | Apr 27, 2026 |
| CITADEL ADVISORS LLC | Increased | 20,077 | May 15, 2026 |
| HRT FINANCIAL LP | New Position | 17,292 | Aug 14, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 10,239 | Aug 13, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Reduced | 6,809 | May 12, 2026 |
| GAMMA Investing LLC | Increased | 2,309 | Jul 7, 2026 |
| RHUMBLINE ADVISERS | Increased | 2,009 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 23, 2026